Morales MV, Bautista MB, Pérez SK, Sánchez AR, Díaz GEJ

Language: Spanish
References: 14
Page: 54-59
PDF size: 188.77 Kb.

ABSTRACT

Cerebral venous thrombosis is an entity with unspecific clinical manifestations and a presentation similar to other types of neurological pathologies; it's early identification and diagnosis can become complex. It is essential to carry out an adequate diagnostic approach with special attention in identifying associated risk factors and the real importance of diagnostic imaging. The treatment of cerebral venous thrombosis is not clearly defined and evidence suggests anticoagulation initially with low molecular weight heparin and subsequently with vitamin K antagonist or oral anticoagulants.

REFERENCES

1. Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020; 83 (4): 369-379.

2. Ulivi L, Squitieri M, Cohen H, Cowley P, Werring DJ. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020; 20 (5): 356-367.

3. Behrouzi R, Punter M. Diagnosis and management of cerebral venous thrombosis. Clin Med (Lond). 2018; 18 (1): 75-79.

4. Arauz A, Barboza MA, Quintero LC, Cantu C, Chiquete E, Serrano F. Prognosis of patients with severe cerebral venous thrombosis treated with decompressive craniectomy. Neurologia (Engl Ed). 2021: S0213-4853(21)00072-4.

5. Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhao P et al. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol. 2019; 76 (12): 1457-1465.

6. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017; 13 (9): 555-565.

7. Yaghi S, Shu L, Bakradze E, Salehi Omran S, Giles JA, Amar JY et al. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke. 2022; 53 (3): 728-738.

8. Ferro JM, Aguiar de Sousa D. Cerebral venous thrombosis: an update. Curr Neurol Neurosci Rep. 2019; 19 (10): 74.

9. Aguiar de Sousa D. Cerebral venous thrombosis: what's new? Hamostaseologie. 2021; 41 (1): 25-30.

10. Ferro JM, Bousser MG, Canhao P, Coutinho JM, Crassard I, Dentali F et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017; 24 (10): 1203-1213.

11. Alimohammadi A, Kim DJ, Field TS. Updates in cerebral venous thrombosis. Curr Cardiol Rep. 2022; 24 (1): 43-50.

12. Ghoneim A, Straiton J, Pollard C, Macdonald K, Jampana R. Imaging of cerebral venous thrombosis. Clin Radiol. 2020; 75 (4): 254-264.

13. Nepal G, Kharel S, Bhagat R, Ka Shing Y, Ariel Coghlan M, Poudyal P et al. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta Neurol Scand. 2022; 145 (1): 10-23.

14. Capecchi M, Abbattista M, Martinelli I. Cerebral venous sinus thrombosis. J Thromb Haemost. 2018; 16 (10): 1918-1931.